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Female genital mutilation/cutting (FGM/C) and fistula are both conditions that have a range of 
health, socioeconomic and lifestyle causes and consequences for women globally. There has been 
sparse empirical and conceptual effort to look at how these two conditions manifest and relate to 
one another. This rigorous review of the literature aims to fill this research gap by assessing the 
state of evidence on the association of FGM/C and fistula and conceptually mapping this 
association within broader social, political, and health systems contexts.  
We applied a systematic approach to reviewing English-language peer-reviewed and grey 
literature and assessed the quality of the evidence using DfID’s Assessing the Strength of 
Evidence guide (DfID 2014) to capture domains such as transparency, appropriateness, reliability, 
validity, and cogency. We applied a non-time bound search strategy through multiple databases 
using a combination of terms that captured the range of names for FGM/C and fistula. In addition, 
we drew on key references and global reports. A four-person reviewer team identified the final list 
of articles from which information was extracted using a data form with open and closed-ended 
questions related to FGM/C, fistula, other health and social consequences, context, population 
sample, study methodology, and quality indicators.  
The review identified 30 full text documents of mixed quality to include in our final analysis. Eleven 
studies formally assessed the association of FGM/C with the occurrence of fistula, out of which 
eight described the conditions as positively related and three described no association. Risks of 
fistula development increase with cut severity. Nineteen studies speculate that these two 
conditions are positively and indirectly related with varying degrees of evidence. Findings also 
covered a range of health consequences of FGM/C and fistula, including maternal and newborn, 
gynecological, and psychosocial consequences; quality of care and health systems capacity 
moderating influences; as well as underlying factors that affect both conditions. In some studies, 
the proposed indirect relationship was physiologically reasoned—namely, that FGM/C-induced 
scarring may lead to the development of fistula by the tightening of the vaginal wall, prolonged 
labour, or deinfibulation following delivery or perineal tears. Others describe key determinants of 
both conditions that lead to a speculative positive association.  
Our review also found that maternal and newborn consequences during pregnancy, labour, 
delivery, and postpartum are the most commonly cited as factors affecting the FGM/C and fistula 
relationship. Beyond obstructed or prolonged labour and fetal distress, particularly in women who 
have undergone FGM/C Type III which predisposes women to developing fistula, maternal 
complications of FGM/C include postpartum hemorrhage, perineal tears and trauma and 
episiotomies; adverse newborn outcomes include infant resuscitation, neonatal death, and low 
birth weight. Gynecological consequences of FGM/C—a subset of which are also consequences 
of fistula—include urogenital outcomes (e.g. scarring, keloids, abscesses, fistula, damaged tissue, 
and cysts), infertility, and reduced sexual functioning and satisfaction. Moreover, women who 
undergo FGM/C and those who develop fistula independently suffer from psychosocial 
consequences such as trauma, fear, depression, and divorce—all of which affect their association.  
Our review additionally found that quality of care and the capacity of the health system to prevent, 
detect, and treat consequences of FGM/C affects the likelihood of a woman developing a fistula. 
Access to instrumental delivery (cesarean sections, episiotomies, and deinfibulation)—particularly 
in severe forms of FGM, is essential to enable women to deliver safely. Studies suggest that the 
efficacy of longer hospital stays for delivery among women with FGM/C is debatable in preventing 
fistula, but the need for sufficient human and material resource capacity for emergency obstetric 
care and newborn resuscitation is clear. Provider knowledge of how to counsel and treat women 
who have undergone FGM/C—in both native and migrant populations—is variable, but overall 
lacking across high, middle and low income contexts. In some cases, this is due to inadequate 
legal and professional guidance.  
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Finally, all the studies describe underlying socio- economic and contextual factors, including 
gender and socio-cultural norms, that affect both fistula and FGM/C. Poverty, an inability to work, 
living in a rural area, limited access to health services, and malnutrition (stunting) increase the 
likelihood of women undergoing FGM/C and developing fistula. The level of education influences 
a family’s choice to continue or abandon the FGM/C practice for a daughter and also has 
implications on their awareness around the importance of antenatal care and facility delivery to 
prevent fistula. The underlying intersectionality of gender with socio-cultural norms around 
controlling one’s sexuality and marriageability (FGM/C) as well as early marriage and pregnancy 
(increases women’s risk for fistula development) all affect the social praise and sanctioning of 
women (cut and uncut/living without and with fistula).  
We have developed a conceptual mapping framework to situate the evidence of an association 
between FGM/C and fistula, including intermediate and underlying factors that relate to both 
FGM/C and fistula high burden settings. High burden settings include high-income countries (HIC) 
and low and middle income countries (LMICs) where migrants or underserved populations lack 
access to proper pregnancy and delivery care. They also include contexts in which women have a 
higher exposure to sexual violence. We recommend that researchers, as well as policy and 
program implementers, think through and utilise the framework developed in their work to consider 
the intersectional influences on both conditions. Qualitatively, it is critical to explore multiple 
perspectives around FGM/C and fistula to better develop contextually sound interventions. 
Quantitatively, we recommend the use of latent variables, scales and indices to investigate the 
influence of positive and negative social norms, health systems, and poverty on both FGM/C and 
fistula in high FGM/C exposure areas. Implementation research around psychosocial factors is 
critical to both conditions as is girl-centered holistic programming. Finally, more research is needed 
on the influence of laws, policies and professional guidelines for health workers on FGM/C (e.g. 
related to re-infibulation and deinfibulation) and how these affect the experiences of women in HIC 





Female genital mutilation/cutting (FGM/C) is the partial or total removal of exterior female genitalia 
or any sort of injury in female genitalia without medical reasons (WHO 2006). WHO categorizes 
FGM into four different types: Type I, or clitoridectomy, refers to the removal of total or part of the 
clitoris and prepuce; Type II, or excision, refers to the removal of total or part of the clitoris and 
labia minora; Type III, also known as infibulation, is the narrowing of the external genitalia and 
stitching together the edges of the vulva; Type IV, known in some contexts as Gishiri, is any kind 
of non-therapeutic procedure including pricking, piercing, incising, and scraping (WHO 2006). An 
estimated 200 million girls and women are currently living with FGM/C with the majority residing in 
30 countries in low and middle income countries (LMICs) in Africa, Asia and the Middle East 
(UNICEF 2016). FGM/C in high income countries (HIC) with migrant populations, such as 
Australia, the United States, the European Union, Norway and Switzerland, is a recognized 
concern as well (Reisel and Creighten 2015).  
Genital fistula is a condition in which a hole between the vagina and the rectum or bladder causes 
a woman to continuously leak urine, feces or both. Though fistulas can be obstetric, traumatic, or 
iatrogenic, the most common type is obstetric fistula (OF). Of the approximate one to two million 
women living with fistula globally, the majority reside in South Asia and sub-Saharan Africa (Adler 
et al 2013). Obstetric fistula affects about 1.57 per 1,000 women in sub-Saharan Africa (SSA). 
Obstetric fistula results from inadequately managed prolonged obstructed labour. Error during 
surgical procedures such as caesarean sections and hysterectomies can lead to iatrogenic fistulas 
(Barageine et al 2104, Sori et al 2016, Raassen et al 2014). Injury, including through sexual 
violence, can lead to traumatic fistula, although this is less common than obstetric and iatrogenic 
fistula in most settings (Longombe 2008). Obstetric fistula is indicative of a health system that has 
failed to provide accessible, timely and appropriate intrapartum care (Tunçalp 2015). The condition 
primarily affects those of lower socioeconomic classes, who are underprivileged, un- or under-
employed, and have limited access to safe delivery attended by qualified health personnel (Wall 
2012, Tebeu 2012, Suzan 2013). Women living with fistula not only suffer from a physically 
debilitating morbidity, but also a loss of healthy life years. The disability adjusted life years weights 
for vesico-vaginal (VVF) and rectovaginal fistula (RVF) are 0.342 and 0.501, respectively 
compared to the 0.187 associated with blindness (Salomon 2015). Women with fistula often exhibit 
poor health indicators including other co-morbidities of obstructed labour and may experience 
negative social consequences including lifelong isolation, stigma, shame, and rejection by their 
husband, family, and community (WHO 2006, Jones 2007, Roush 2009, Mselle 2012).   
FGM/C and fistula represent complex conditions that reflect socio-economic, cultural, legal, and 
health systems determinants of women’s health (Kimani et al 2016). There is a lack of literature on 
these determinants as well as the factors that are associated with prevention, identification, 
management, and counseling for either condition. Despite the existence of independent literature 
on FGM/C (Almroth-Berggren 2001, WHO 2006, WHO 2013) and fistula (Bellows et al 2015, 
Ahmed 2015), there is limited research on the association of the two conditions. Moreover, there 
is little concurrence on the intensity of the health risks associated with different types of FGM/C 
and how cut severity relates to various types of fistula (Slanger et al 2002). It is plausible, given 
the proximity and relationship of the FGM/C site to genital fistula, implications of pregnancy and 
childbirth, informal cutting procedures and the context of FGM/C, that FGM/C could lead to the 
development of fistula (obstetric, traumatic, iatrogenic). To date, to the best of our knowledge, 
there has been no conceptual work mapping the association between FGM/C and fistula. 
This rigorous review seeks to fill this research gap and aims to 1) assess the state of evidence on 
the association of FGM/C and fistula, 2) conceptually map this association within broader social, 
political, and health systems contexts, 3) identify evidence gaps and areas for further research, 
and 4) develop recommendations for policy and programming. 
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Methods 
We conducted a rigorous review of English-language peer-reviewed and grey literature, drawing 
upon processes identified in DfID’s Assessing the Strength of Evidence guide (2014). We applied 
a search strategy using the following terms in combination with each other and as Medical Subject 
Headings (MeSH) terms: ‘female genital mutilation’, ‘FGM’, ‘female genital cutting’, ‘FGC’, ‘female 
circumcision’, ‘infibulations’ AND ‘fistula’, ‘obstetric complications’, ‘obstetric consequences’, ‘types 
of tears’, ‘excision’, and ‘delivery outcomes’. The databases and search engines utilised included 
PubMed, Google Scholar, Scopus, JSTOR, and Brandeis Scholar as well as organizational 
databases including Population Council, UNFPA, and EngenderHealth. Our search did not apply 
time nor geographic restrictions. In addition to the database searches; we drew upon key 
references cited in review articles and global reports.  
Our search strategy (Figure 1) yielded a total of 512 records. Upon screening of titles and abstract 
review, 422 records were excluded and 61 articles, reports, and academic theses were identified 
as eligible for full text review. A four-person team read and reviewed the full text documents 
identified. Each full text document was reviewed by two independent readers and classified as “to 
include”, “to exclude”, “not sure”. Any discrepancy between two reviewers was deliberated and 
jointly reviewed by the research team. Thirty full text documents were selected for inclusion in the 
body of evidence exploring the association between FGM/C and fistula. Articles were excluded if 
FGM/C and fistula were not mentioned in the articles’ findings.  
Data were collected through a Google survey form jointly developed by the research team after 
critical reflection of an initial set of peer-reviewed articles and grey literature. Descriptive measures 
extracted include authors’ names, publication year, country or countries (region) in which the study 
was conducted, research type (primary, secondary), sample size and population, study design 
(observational, systematic review, other review), analytic methods used (qualitative, quantitative, 
mixed), data sources (community, facility, other), and data collection time-frame. Reviews without 
a specific indication of sample size (number of studies reviewed) were labeled “NI” (not indicated); 
similarly, facility and community data sources were classified as not applicable (N/A). Research 
questions, objectives, and key findings were extracted through open-ended responses. 
Figure 1. Search strategy flow diagram 
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Both formal and speculative associations of FGM/C and fistula were abstracted from each article—
formal associations refer to those that were explicitly assessed in the results’ section and 
speculative relationships that may be implicit or explicitly mentioned in the results and discussion 
with or without data and reference support. Direct, indirect, and inconclusive associations were 
also extracted. Formal associations were categorically deemed positive (increase in FGM/C, 
increase in fistula), indirect/did not describe (which included indirect associations and those that 
weren’t explicitly described), or none (i.e. ‘no association’). Speculative associations were 
classified as positive (if increase in FGM/C, increase in fistula is supported by data or reference), 
indirect/did not describe (indirect association through prolonged labour, but lacked explicit 
descriptive link), and none (i.e. ‘no association’). Negative associations between FGM/C and fistula 
were not seen nor extracted. Review 1 and Review 2 findings were jointly analysed and reconciled 
to obtain findings on the association of FGM and fistula. 
Reviewers additionally assessed the health and social causes and consequences, including 
contextual factors that influence FGM/C and fistula using open- and close-ended questions. 
Obstetric and newborn complications—including postpartum hemorrhage (PPH), pre-term births, 
sepsis, prolonged labour, maternal death, newborn death and newborn complications – and mode 
of delivery (e.g. cesarean section, episiotomy, vaginal birth) were explicitly extracted. Open-ended 
questions about any other emerging associations with FGM/C and fistula allowed reviewers to 
extract data on a range of other health and social factors including physical (gynecological, sexual 
functioning, other) and psychological factors, health systems capacity, underlying poverty, gender 
dynamics, education, socio-cultural norms and legal contexts. 
Finally, the quality of evidence was assessed using 19 questions, informed by DFID’s ‘Assessing 
strength of the evidence’ report, as listed in Table 1. Questions were evaluated as both binary and 
3-point responses resulting in a total potential score of 29 points. Each article’s score was 
calculated and quality level classified in its relation to the maximum score as ‘high’ (>75% score), 
‘moderate’ (50-75% score) or ‘low’ (<50% score).  
Data were analysed using mixed methods. Closed-ended questions were tabulated and analysed 
quantitatively using Microsoft Excel. Textual analysis of open-ended questions around causes and 
consequences of FGM/C and fistula was conducted by the research team through deliberation and 
corroborating reviewer responses. 
Table 1. Assessing quality of evidence 
Quality Area Specific question Responses 
Conceptual framing  Does the study acknowledge existing research?                   {0: no, 1:yes} 
Does the study construct a conceptual framework?           {0:no, 1:yes} 
Does the study pose a research question or outline a 
hypothesis? 
{0:no, 1:yes} 
Transparency     
  
Does the study present or link to the raw data it analyses?  {0:no, 1:yes} 
Did the authors describe the geography/context in which the 
study was conducted?           
{0:no, 1:partially, 2: in a detailed 
way} 
Does the study declare sources of support/funding? {0:no, 1:yes} 
Appropriateness 
  
Does the study identify a research design? {0:no, 1:yes} 
Does the study identify a research method? {0:no, 1:yes} 
Does the study demonstrate why the chosen design and 
method are well suited to the research question?              
{0:not at all, 1: describes partially, 
2: strongly describes} 
Cultural sensitivity  Does the study explicitly consider any context-specific cultural 




To what extent does the study demonstrate measurement 
validity? 
{0:low, 1: moderate, 2: high} 
To what extent is the study internally valid?  {0:low, 1: moderate, 2: high} 




To what extent are the measures used in the study stable?  {0:not very, 1:moderately, 2:very} 
To what extent are the measures used in the study internally 
reliable? 
{0:not vary, 1:moderately, 2:very} 
To what extent are the findings likely to be 
sensitive/changeable depending on the analytical technique 
used?  




Does the author ‘signpost’ the reader throughout?  {0:no, 1: yes} 
To what extent does the author consider the study’s limitations 
and/or alternative interpretations of the analysis? 
{0:does not, 1:moderately, 
2:strongly} 






Descriptive characteristics of the 30 final documents (detailed in Appendix 1, Table 2) show that 
more than half (23 of 30) were published between 2000 and 2016 and comprise both grey (8) and 
peer-reviewed (22) literature. Documents were classified as primary research studies (n=18, 60%) 
and reviews (n=12) and applied qualitative (13), quantitative (13), and mixed methods (4). With the 
exception of one high income country investigation, the majority of studies were in Africa, in low- 
and medium income countries, including Nigeria (5), Kenya, (3), Ethiopia (3), Egypt (2), and Sudan 
(1). The 14 multi-country studies covered both LMIC and HIC settings. Six of the primary studies 
focused on women following their fistula repair surgeries; eight explicitly looked at women 
attending antenatal (ANC), maternity, family planning (FP), and postnatal (PNC) services; and four 
explored health service provider and other stakeholder perspectives; the latter included nurses, 
midwives, surgeons, and obstetricians and gynecologists as well as policymakers, opinion leaders 
and community members. Although the majority of data sources were collected in facilities through 
record review, clinical observation, and self-reporting, two qualitative studies explicitly drew on 
community-based sources, and one quantitative secondary analysis of household surveys. 
Timeframes for primary studies’ data collection ranged from under six months (n=6), six months to 
one year (n=3), and over a year (n=6); the longest were those focused on fistula patients, typically 
between three and 11 years. Sample sizes ranged from eight to 35,037; eight studies had fewer 
than 100 respondents, three studies had between 101 and 200, and nine had over 200. Nine 
studies, all of which were secondary reviews, did not explicitly describe the number of articles 
reviewed.  
An array of research questions and objectives were asked in the studies, focusing either on 
FGM/C, fistula, or both. Only two studies presented a conceptual framework (Berg et al 2014, 
Fantu 2007). With the exception of one study that explicitly set out to study the direct association 
of FGM/C and fistula (Browning et al 2010), rarely did the studies focus on this association. Rather, 
the reviewed articles sought to explore broader confounding, modifying, and mediating factors 
relating to both conditions. Research questions and objectives were under the following aims: 
 To study the prevalence and the social and health consequences of fistula (n=5) 
 To study the association between FGM/C and obstetric complications (n=7) 
 To study the social and health consequence of FGM/C (n=13) 
 To understand the type, context, and management of FGM (n=4) 
 To study health center readiness to treat FGM/C or fistula (n=2) 
Association between FGM/C and Fistula  
Of the 30 articles, 11 articles formally assessed the association of FGM/C with the occurrence of 
fistula, out of which eight described the conditions as positively related and three described no 
association. Eighteen studies speculated that these two conditions were indirectly positively related 
with varying degrees of evidence (Table 3).
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Type of association 
between FGM/C and 
fistula (formally 
assessed) 
Type of association between 
FGM/C and fistula 
(speculative/assumed) 
Jaldesa G, Askew I,  Njue C, Wanjiru M 2005 NI; (e.g. III)  Positive  
Jones H, Diop N, Askew I, Kabore I 1999 I, II, III Positive  
Mabeya HM 2004 III Positive  
Saracoglu M, Zengin T, Ozturk H, Genc M 2014 IV (Gishiri) Positive  
Sharfi AR, Elmegboul MA, Abdella AA 2013 I, II, III, IV  Positive  
Tahzib F 1983 IV (Gishiri) Positive  
Tukur J, Jido TA, Uzoho CC 2006 IV Positive  
WHOa 2000 I, II, III, IV Positive  
Browning A, Allsworth JE, Wall LL 2010 I, II None  
Peterman A & Johnson K 2009 I, II, III None  
Slanger TE, Snow RC, Okonofua FE 2002 I, II, III, IV None  
Al-Hussaini TK 2003 I ,II   Indirect /did not describe 
Berg RC, Underland V, Odgaard-Jensen J, Fretheim A, Vist GE 2014 NI, review  Indirect /did not describe 
Creighton SM 2015 NI, review  Indirect /did not describe 
Fantu T 2007 Type II  Indirect /did not describe 
Ibekwe PC, Onoh RC, Onyebuchi AK, Ezeonu PO, Ibekwe RO 2012 NI  Indirect /did not describe 
Kasim K, Shaaban S, Sadak AEAE, Hassan H 2012 NI  Indirect /did not describe 
Khisa M, Nyamongo IK 2012 NI  Indirect /did not describe 
Kimani S, Mutesi J, Njue C 2016 NI, review  Indirect /did not describe 
Magoha GAO, Magoha OB 2000 NI, review  Positive 
Mumtaz A, Mohammed R 2007 NI, review  Indirect /did not describe 
Onuh, SO, Igberase GO, Umeora JOU, Okogbenin SA, Otiode VO, Gharoro EP 2006 NI  Indirect /did not describe 
Reisel D, Creighton SM 2015 NI, review  Positive 
Ruiz JI, Martinez AP, Bravo PMM, Roche PF 2012 NI, review  Positive 
Rushwan H 2000 NI, review  Positive 
Ryan F 2012 NI 
 
Indirect /did not describe 
Teufel K, Dorfler DM 2013 NI, review  Positive 
Toubia N 1994 NI, review  Positive 
UNFPA and Engender Health 2003 NI 
 
Indirect /did not describe 
WHOb 2006 I, II, III, IV 
 
Indirect /did not describe 
*NI: not indicated explicit 
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Formal assessment of association of FGM and fistula 
Eleven studies, including primary and secondary designs, in LMIC settings with high FGM/C 
prevalence (56% to 95%), formally assessed the association of fistula and FGM/C, with mixed 
findings reflecting both direct and indirect relationships (Table 4). Among mostly obstetric fistula 
patients in Kenya, 80 percent had undergone Type III FGM/C (Mabeya 2004). In northern Nigeria, 
where Type IV FGM/C (gishiri) is common, nine to 18 percent of fistulae were attributed to trauma 
(i.e. cutting process or sexual violence) in addition to 60 percent attributed to obstetric situations 
(Tahzib 1985, Tukur et al 2006). Among women in Mali and Burkina Faso clinics who had 
undergone FGM/C and had developed obstetric complications, two and one percent, respectively, 
reported developing obstetric fistula (Jones et al 1999). Among Sudanese women attending clinics 
who had undergone FGM/C, 9.2 percent and 14.6 percent developed vesico-vaginal fistula (VVF) 
and recto-vaginal fistula (RVF), respectively. Two studies in Ethiopia and Nigeria found no 
association between FGM/C (Type I and II) and the development of obstetric fistula (RR/OR ~1.0).  
The studies demonstrate variability and a distinct pattern of FGM/C and fistula association by 
FGM/C types. Positive associations are reported in studies investigating Type III (infibulation) and 
Type IV (gishiri) FGM/C only (Jaldesa et al 2005, Mabeya 2004, Saracoglu et al 2014, Tahzib 
1985, Tukur et al 2006), or in studies of all FGM/C types, individually or in aggregate (Jones et al 
1999, Sharf et al 2003, WHOa 2000). Studies with no evidence of association report on fistula 
effects in populations with greater exposure to Types I and II FGM/C and lack sufficient data to 
assess Type III’s contribution to obstructed labour or fistula (Browning et al 2010, Peterman and 
Johnson 2009, Slanger et al 2002). One study (Jones et al 1999) that considered FGM/C Types I, 
II and III, demonstrated that the risk of developing fistula increases with the severity of FGM/C cut.  
Quite a few of the formally assessed studies, including those finding no direct statistical association 
between FGM/C and fistula, describe indirect associations (e.g. via prolonged labour, scarring, 
tears) and mention contextual, personal, and health systems factors that may influence both 
conditions and confound the association (Mabeya 2004, Tukur et al 2006, Slanger et al 2002). 
Speculative association  
Out of the 30 studies, 19 suggested, either explicitly or through presentation and discussion of 
intermediate factors, association between FGM/C and fistula (Table 5): These studies present 
indirect mechanisms through which FGM/C affects fistula through related health consequences, 
including those that might occur at childbirth, and moderated by levels clinical management. Six 
multi-country reviews (Table 5) explicitly speculated that fistula is an outcome of FGM/C (mainly 
Type III); five indicated that fistula as sequelae to long-term obstetric complications (prolonged 
labour, perineal or paraurethral tears) and poor clinical management (of episiotomy or instrumental 
delivery), while one suggested that the transformation of an infibulation-induced infection into an 
abscess propels fistula development (Ruiz et al 2012). Some studies speculated that at the time 
of, and immediately following, cutting procedures (particularly infibulation), women are at risk for 
urinary and traumatic fistula, as late complications due to  injury while being cut (Magoha and 
Magoha 2000, Muntaz and Mohammed 2007, Reisel and Creighton 2015, Ruiz et,al 2012). 
The other 13 studies elaborated long-term health consequences incurred during childbirth (Table 
5) but implied only indirect relationships to fistula, reporting that fistula can be caused by vaginal 
wall tightening resulting in FGM/C-induced scarring, prolonged labour, or deinfibulation during 
delivery or perineal tears that may result in both RFV or VVF (Tal-Hassaini 2003, Reisel and 
Creighton 2015, Teufel and Dorfler, Rushwan 2000, Slanger et al 2002). Although these articles 
do not directly causally link FGM/C and fistula, they mention key intermediate conditions 
comparable to those in the articles explicitly offering speculative positive associations.  
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Table 4. Studies in which associations were formally assessed 
Author Methods and sample 
Prevalence of FGM/C or 
fistula 
Study setting 




Jaldesa et. al., 
2005 
Mixed methods exploratory:  
In-depth Interview-FGDs, Facility 
assessments, Client exit interviews 
attending ANC, & service provider interviews 
FGM/C: 97.5% 
Fistula: 2-3% (reported by 
nurse-midwife)  
Two districts in Kenya (one 
urban and other rural) with 
women of the Somali ethic 
community and providers 
NI; 
(e.g. III) 
Qualitative data from providers suggest FGM indirectly 
leads to fistula (VVF and RVF) via difficult delivery due to 




Retrospective facility and patient survey 
(clinical observation & self-report)  
5337 women attending clinic for range of RH 
and maternal services 
FGM/C: 93%-94% 
477 (of 5337 women at clinic) 
women developed 
gynecological complications 
due to FGM 
Mali (rural and urban) and 
Burkina Faso (rural) 
I, II, III 
Eight out of 477 women who had delivery complication 
had fistula.  
1% of women who had undergone FGM and developed 
obstetric complications in Burkina Faso and Mali reported 
VVF; in Mali an additional 1% reported RVF. 
Mabeya 2004 
Retrospective facility-based record review 
66 women who received fistula repair 
surgeries 
Fistula: 0.1 % Two rural districts in Kenya III 
80% of repaired women  had undergone severe 
FGM/infibulation 
Sharfi et. al., 
2003 
Retrospective patient survey  
2000 women (including university students 
and women attending outpatient clinic) 
FGM/C: 73.4% 
Type III: 63% 
A Sudanese university 
tertiary hospital in Khartoum 
I, II, III, IV 
(majority: type 
III) 
9.2% (n=57) of women developed VVF 14.6% (n=90) 
developed rectal vagina fistula. VVF occurred as a result 
of prolonged obstructed labour. 




NI Multicounty IV (Gishiri) 
Gishiri cut is common among Hausa's living in Northern 
Nigeria and Southern Niger. 5.68 to 18% of all the fistulae 
cases in the region result from Gishiri. 
Tahzib F, 1985 
Facility record reviews 
1443 fistula repair patients, out of which 80 
were pediatric cases (<13 years) 
NI University hospital in, 
Northern Nigeria 
IV (Gishiri) 
60%, 15%, and 9% of pediatric fistula cases resulted from 
prolonged labour, Gishiri cut, and trauma (sexual 
violence), respectively.   
Tukur et al, 
2006 
Facility record reviews 
50 consecutive fistula patients 
Fistula incidence: 150,000-
2000,000 cases/year 
Jigawa state, Northern 
Nigeria 
IV 
After prolonged obstructed labour, the most common 
cause of VVF was the Gishiri cut (18%) administered by 





I, II, III, IV 
7 studies looked at the association, 4 of which found that 
Type III and IV lead to the development of fistula though 
obstructed labour, vulval scarring, anatomical distortion 
and incorrectly performed episiotomy (Damas 1972, 
Shandall 1967, De Villeneuve 1937 and Pieters 1972). 
Indirect positive association through obstructed labour was 
speculative (Tahzib, 1985; Harrison, 1983). 
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NO ASSOCIATION 
Browning. A et 
al 2010 
Facility record/ case notes review – 
comparative study 
492 fistula patients who were cut (255) and 
uncut (237) 
FGM/C: 81% 
Fistula center, Amhara, 
Ethiopia 
I, II 
There is no independent association between Type I and II 
FGM/C the development of obstetric fistula from 
obstructed labour (RR = 0.93, 95% CI 0.85, 1.02). There 
was no association between FGC and urinary 
incontinence (RR = 0.92, 95% CI 0.82, 1.03). 
Peterman A & 
Johnson K, 
2009 
DHS secondary analysis of population-level 
surveys 
35037 women of reproductive age (15-49 
years) across Malawi (11,698), Rwanda 
(11,321); Uganda (8524) and Ethiopia 
(4,066) 
NI 
Community – households in 
Malawi, Rwanda, Uganda, 
and Ethiopia 
I, II, III 
No statistically significant evidence that FGM/C 
contributes to the prevalence of incontinence (OR = 0.819, 
95% CI -0.299, 0.137). In this study, incontinence was 
used as a proxy for fistula –both traumatic and obstetric. 
Slanger et al., 
2002 
Facility-based comparative study (self-
reported on first delivery) 
1107 women attending FP or antenatal 
services (with at least one child) 
FGM/C: 56% (n=621 in study); 
25% (country) 
Edo, Nigeria I, II, III, IV 
No difference in complications and procedures was found 
between those who had undergone types I and II FGM/C 
and those who were uncut. Both obstructed labour and 
perineal tears (major contributing factors to fistula) – odds 
were not significantly associated with FGM. 
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Table 5. Speculative associations between FGM/C and fistula 





Magoha and Magoha, 2000 FGM/C may cause fistula in the long term 
through injury of urological organs such as 
the uterus and bladder. 
Review; cited two articles as 
evidence (Baker et al. 1993; 
Dirie and Landmark 1992) 
Reisel and Creighton 2015 FGM/C may lead to damage to the urethra 
and urethral strictures and lead to fistula 
formation. 
Review; cited Amin et al. 
2013 as evidence  
Toubia 1994 Infibulated (Type III FGM/C) women: 
during labour, the fetal head may get 
obstructed and lead to VVF. 
Review; cited Warsame 
1989 as evidence 
Ruiz et,al., 2012 Cut women may have infection that 
evolves into an abscess and progresses 
to fistula development. 
Review; did not present data 
or refer to an article 
Teufel and Dorfler, 2013 FGM/C leads to prolonged delivery 
resulting to VVF in some cases; in other 
instances, necrosis and perineal tear from 
FGM/C lead to fistulae. Very tight 
circumcision scar may lead to what is 
normally referred to as dribbling 
incontinence. 
Review; did not present data 
or refer to an article 
Rushwan. H, 2000 Infibulation could increase the risk of 
fistula through prolonged labour and 
constant pressure of the fetal heal on 
adjacent organs. 
Review; did not present data 




Al Hussain 2003 
Berg et al. 2014 
Creighton 2015 
Fantu 2007 




Mumtaz & Muhammed 2007 
Onuh et al. 2006 
Ryan 2012 
UNFPA & EngenderHealth 2003 
WHOb, 2006 
Described long term complication of 
FGM/C such as prolonged labour, 
perineal tear, episiotomy, postpartum 
hemorrhage, perineal trauma and 
caesarean section, difficult delivery, 
episiotomies. 
Data includes primary data, 
secondary data and review 
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Health and Social Consequences of FGM/C and Fistula 
Nearly all the studies report that FGM/C has consequences for a woman’s physical and mental 
health, from the moment she is cut as a child, throughout her adult life (Berg et al 2014). The most 
common immediate or short-term consequences described include bleeding, sepsis, urine 
retention, urethral injury, and urinary fistula (Sharfi et al 2013, Toubia 1994). Consequences due 
to fistula include serious bad odor due to continuous dripping of urine or feaces and stillbirths 
(UNFPA and EngenderHealth 2003). Long-term health consequences of FGM/C, described in 26 
of the 30 articles, include maternal, newborn, and gynecological complications. The psychosocial 
consequences of FGM/C overlap with those of fistula. In some cases, consequences of FGM/C 
are the causes of fistula. 
Maternal and newborn consequences 
Maternal and newborn consequences and outcomes during pregnancy, labour, delivery and 
postpartum are the most commonly cited intermediate factors in the FGM/C and fistula relationship. 
Obstructed or prolonged labour is the largest risk factor for obstetric fistula. Sixteen studies 
describe scenarios where FGM/C scarring, and in cases of Types III and IV, leads to a narrowing 
of the vaginal orifice and fetal distress. This combined with prolonged labour predisposes women 
to developing fistula (Mabeya et al 2004, Jaldesa et al 2005, Teufel and Dorfler 2013, Fantu 2007, 
Tukur et al 2006, Sharfi et al 2013, Toubia 1994, Khisa and Nyamongo 2012, Slanger et al 2002, 
Kasim et al 2012, Magoha and Magoha 2000). Infibulated women are 2.5 times more likely to 
develop any kind of obstetric complication than uncut women (Jones et al 1999). Given the nature 
and severity of Type III FGM/C, these women in particular risk perineal tears and need de-
infibulation during ANC or delivery care to safely give birth (Toubia 1994 and Rushwan 2000).  
Thirteen articles described PPH as a consequence of FGM/C or hemorrhage at the time of the 
FGM/C procedure (Sadak et al, Jaldesa et al 2005, Kimani et al 2016, Onuh et al 2016, Kasim et 
al 2012, Mumtaz and Mohammed 2007, Reisel and Creighton 2015, Ruiz et al 2012, Sharfi et al 
2013, Toubia 1994, Teufel and Dorfler 2013, WHOb 2006). Seven articles cite perineal tears, 
trauma, and episiotomy as long-term consequences of FGM/C (Creighton et al 2015, Reisel and 
Creighton 2015, Kimani et al 2016, Magoha and Magoha 2000, Slanger et al 2002, WHOb 2006, 
WHOa 2000). At least six articles mention maternal death as a consequence of FGM/C (WHOa 
2000, Kimani et al 2016, Tukur et al 2006, Ruiz et al 2012, Teufel et al 2013) and 11 report newborn 
deaths or health complications due to FGM/C (WHOa 2000, Tukur et al 2006, Jones et al 1999, 
Toubia 1994, Ruiz et al 2012, Teufel and Dorfler 2013, Fantu 2007). Similarly, stillbirths often co-
occur with obstetric fistula, given the precursor of prolonged labour (UNFPA and EngenderHEalth, 
2003). According to one systematic review (WHOb 2006), despite unclear explanatory 
mechanisms, women who have undergone FGM/C are more likely to suffer adverse newborn 
outcomes including infant resuscitation, neonatal death, and low infant birth weights.  
Gynecological consequences 
The gynecological consequences of FGM/C revealed in the studies include urogenital outcomes, 
infertility, and sexual functioning and satisfaction. Urogenital outcomes such as scarring, keloids, 
abscesses, fistula, damaged tissue (perineum, anal sphincter), disfigurement, vaginal obstruction, 
and cysts are mentioned in the background sections of studies but are not frequently reported in 
the research findings (Kimani et al 2016). Five of the 30 articles describe urogenital infection, urine 
retention, and other moderating factors after FGM/C that could lead to fistula development 
(Creighton et al 2015, Magoha and Magoha 2000, Sharfi et al 2013, Tukur et al 2006). To address 
these compounding factors in clinics, some studies stress the need for specialised provider training 
12 
and to involve urologists in fistula surgery teams for successful repair (Creighton et al 2015, 
Magoha and Magoha 2000). Although it may not have implications on obstetric fistula, infertility, 
reported as a late complication of FGM/C (Tahzib 1983), is more common (2.9 times increased 
likelihood) among cut women (Kasim et al 2012). Quite a few articles describe women who had 
undergone FGM/C as more likely to report painful intercourse, no sexual desire, less sexual 
satisfaction, and less experience of orgasm compared to uncut counterparts (Khisa and Nyamongo 
2012, Kimani et al 2016, Saracoglu et al 2014, Sharfi et al 2013). 
Psychosocial consequences 
Women who undergo FGM/C as well as those who develop fistula independently suffer a number 
of psychosocial consequences. Understanding how these consequences interrelate may have 
implications for the associations between the two conditions. At least five articles found that women 
who had undergone FGM/C suffered from psychosocial consequences such as trauma, fear, 
depression; in some cases, these led to or were compounded by divorce (Tahzib et al 1983, 
Creighton et al 2015, Browning 2010, Jaldesa et al 2005, Saracoglu et al 2014, Teufel and Deufel 
2013). In cases where women migrate to new contexts where FGM/C is less prevalent, the shock 
around its non-normative practice also has psychosocial consequences for a woman (Teufel and 
Deufel 2013). Psychosocial consequences suffered by women living with fistula include isolation, 
prejudice, depression, and anxiety, many of which are mitigated by divorce or living separately 
from one’s husband or family (Khisa 2015, Tahzib 2015). 
Quality of care and health system capacity 
Quality of care and the capacity of the health system emerged as a potential mediator in the 
association between FGM/C and fistula. Qualitative and quantitative findings suggest that 
improving the capacity of the health system to prevent, detect, and treat consequences of FGM/C 
affects the progression to fistula (Sharfi 2013, Mabeya 2004, WHOb 2006, Onuh et al 2006). 
Twelve out of the 30 articles describe that FGM/C and delivery type, including access to 
instrumental delivery (cesarean sections, episiotomies, de-infibulation), is essential to enabling 
women to delivery safely (Slanger et al 2002, Teufel et al 2013, Onuh 2006, Creighton 2015, 
Kimani et al 2016). In contexts where a needed episiotomy was not performed, women who have 
undergone FGM/C have 1.31 to 3.19 times higher relative risk of a perineal tear compared to uncut 
women (WHOb 2006). This risk increases with cut severity: 1.31 greater for those with Type I, 1.92 
times greater for those with Type II, and 3.19 for those with Type III. Instrumental delivery is critical, 
especially for women living with Types III and IV. Some studies observed that women with FGM/C 
require extended hospital stays (WHOb 2006), while others suggest no difference (Creighton 2015, 
Browning 2010). Many studies advocate that hospitals need human and material resource capacity 
for newborn resuscitation and emergency obstetric care (EmOC) to avoid fistula, mitigate other 
maternal consequences (potentially intensified by FGM/C), and avoid newborn death or morbidity 
(Browning 2010, Kimani et al 2016, WHOb 2006). The provision of timely and personalized ANC 
for women with FGM/C where women are counseled on the importance of skilled birth attendance 
and deinfibulation in preparation of a vaginal delivery also emerged as critical in HIC and LMIC 
contexts (Jones et al 1999, Rushwan 2000, UNFPA and Engender Health 2003).  
Provider knowledge of how to counsel and treat women who have undergone FGM/C is variable 
by context. There was less understanding in HICs as FGM/C cases were concentrated among 
migrant women (Creighton 2015, Rushwan 2000, Reisel and Creighton 2015). In these settings, 
inadequate or a complete lack of legal and professional guidance constrains providers from 
managing FGM/C clients appropriately—including policies on re-infibulation and de-infibulation 
(Reisel and Creighton 2015). De-infibulation by traditional birth attendants (or unskilled attendants) 
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can cause fistula in some cases (Browning 2010, Toubia 1994, Onuh et al 2006). One study in 
Kenya showed five in eight women with FGM/C developed fistula during their first delivery due to 
the unskilled birth attendant with whom they delivered (Khisa and Nyamongo 2013). Capacity 
building of skilled assistants in many LMICs where women have less access is critical (Jaldesa et 
al 2005).  
Underlying contextual factors influencing both fistula and FGM 
Nearly all studies in either the results or interpretation sections, touch on one or more underlying 
socio- economic and contextual factors that affect both fistula and FGM/C, including poverty, place 
of residence, and malnutrition. For example, women living in poverty, who are unable or not 
allowed to work for pay, have limited access health services and have a higher likelihood of 
continuing FGM/C, are at greater risk of developing fistula. These women have the lesser means 
to deal with the health and social consequences of either condition (Ryan 2012, Jones et al 1999, 
Fantu 2007). Women living with fistula are further unable to work given the constant smell they 
emit, which plays into their cycle of poverty (UNFPA and EngenderHealth 2003). In high 
prevalence FGM/C areas, malnutrition, which stunts pelvic growth predisposing some women to 
prolonged labour and elevates their risk of fistula, may further contribute to FGM/C-fistula indirect 
association (Mabeya 2004). The level of education may influence a family’s choice to continue or 
abandon the FGM/C practice for a daughter. Mothers and fathers with more schooling tend to 
discontinue the practice over generations (Fantu 2007, Ibekwe et al 2012). Education also affects 
awareness around the importance of antenatal care and facility delivery, both of which help women 
with FGM/C to identify prolonged labour and seek skilled care to prevent fistula.  
Studies also demonstrate that gender and socio-cultural norms with respect to women’s relational 
roles to spouses and families affect FGM/C and fistula. While early marriage and pregnancy places 
women at risk for fistula (Mabeya 2004, UNFPA and EngenderHealth 2003), FGM/C is often 
described as way to control women’s sexuality (Ibekwe et al 2012). Moreover, the reduced sexual 
satisfaction and strained marital relationships due to FGM/C and fistula described by many studies 
(UNFPA and EngenderHealth 2003, Jaldesa 2005, WHO 2006) have implications for gender-
dynamics in households. In both cases, the intersectionality of gender and socio-cultural 
preferences around women are at stake. Socio-cultural, including religious, norms around 
marriageability, virginity, sexuality and social status influence FGM/C (Magoha and Magoha 2000, 
Kimani et al 2016, Ruiz et al 2012, Saracoglu et al 2014). Social sanctioning for uncut women (un-
marriageability, promiscuity, dishonor) tends to sustain the FGM/C practice (Ibekwe et al 2012, 
Browning et al 2010), though these normative claims are rarely assessed in quantitative 
assessments. Social sanctioning of women living with fistula in many cases relates to their isolation 
from family and community spaces as well as their inability to remain employed due to their leaking 
condition (Khisa and Nyamongo 2012, Fantu 2007, Onuh et al 2006). Less information exists on 
sexual violence and/or rape though it is described as influencing fistula formation (Peterman and 
Johnson 2009), there is insufficient evidence on how it affects the relationship of FGM/C’s with 
fistula (Tahzib 1985, Fantu 2007).  
Quality of evidence 
The quality of evidence is mixed on the association of FGM/C and fistula (Table 2). Of the 30 final 
documents, 12 (40%) are of high quality, 13 (43%) of medium quality, and five (17%) are classified 
as low quality studies. This mixed level of evidence on a relatively under-studied issue reflects 
manuscript transparency, cogency, and moderate reliability and transferability of findings, as 
opposed to an inability to draw significant causal inferences from the limited study designs. Most 
were facility-based record reviews, of both primary and secondary designs, that although provide 
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clinical evidence, do not enable us to ascribe a population-based assessment of the association 
of FGM/C and fistula. Comparative studies that looked at uncut and cut women were helpful, 
although rarely was fistula a focused outcome. Primary qualitative and quantitative studies were 
strongest when they insight into the broader context that influenced both FGM/C and fistula. 
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Discussion 
Summary and conceptual mapping 
This review sought to describe the existing evidence on the association of FGM/C and fistula and 
found mixed evidence that reflects both direct and indirect relationships. We found 30 peer-
reviewed and grey literature studies that commented on both conditions; while 11 documents 
formally demonstrated positive and no association between FGM/C and fistula, many others 
speculate about positive relationships. The dissonance between speculative and evidence-based 
associations demonstrates a lack of formal rigorous quantitative measures (relative risks and odds 
ratios) investigating the FGM/C and fistula relationship. Interestingly, the three documents that 
confirmed no association were carried out in contexts of predominantly FGM/C Types I and II, 
while those that saw positive associations covered all or focused on FGM/C Types III and IV, 
indicating a potential dose-response of severity, i.e. the more severe the cut, the more likely a 
woman is to develop pregnancy and other complications that lead to fistula development. Within 
these higher severity types, Type III was often associated with obstetric fistula, while Type IV was 
additionally linked to traumatic fistula caused by cutting procedures themselves. We also found 
that the indirect association of FGM/C and fistula, including via intermediate health and social 
consequences of FGM/C, mediating health systems challenges, and underlying socio-economic 
and context factors, are critical to consider in conceptually framing the two conditions in a way that 
helps frame implications for research and practice (Figure 2). 
Figure 2. Conceptual mapping of associations between FGM/C and fistula 
EmONC refers to emergency obstetric and newborn care and ANC refers to antenatal care 
This conceptual framework demonstrates the complexity of factors identified through our review 
that affect both FGM/C and fistula. In addition to the direct and mediated pathway through which 
FGM/C leads to the development of fistula, there are health consequences of both conditions that 
may influence the association. Though the data on severity is mixed and insufficiently identified in 
articles (Table 3), the conceptual framework maps our current understanding. Moreover, the 
similarities in sociodemographic, economic and cultural context of women exposed to both FGM/C 
and fistula is reflected in their lack of access to health care services broadly and in the specific 
context of pregnancy and childbirth; this moderates the association between the two conditions. 
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Quality of antenatal and delivery care, including the facility material and human resource mix, 
adequate legal and professional guidance, as well as the competency and sensitivity required of 
providers tasked with counseling women exposed to both conditions plays a mitigating role. Finally, 
FGM/C and fistula are situated in settings with shared underlying societal factors that affect our 
ability to capture a measurable association between the conditions. The intersectional influence of 
socio-economic (wealth, education) and poverty statuses—including women’s abilities to maintain 
employment, gender dynamics including women’s autonomy to make health care-seeking 
decisions, socio-cultural norms and sanctions related to marriageability, cleanliness, and women’s 
sexuality—determine both FGM/C and fistula. These underlying and health systems causes and 
consequences of both conditions demand more attention in terms of research, programming, and 
policy in LMICs and HICs. 
Limitations 
We faced several challenges in carrying out this review. First, given the complexity of both 
conditions, there were only a few studies that captured a diverse range of perspectives (qualitative) 
and reached adequate samples to comment statistically significantly on associations and their 
strength (quantitative). Secondary analyses were predominantly clinical cases, or other reviews, 
that did not adequately define replicable methodologies or provide clear evidence of assessing an 
association. A number of studies took place in facility settings where women received surgical 
repair or instrumental delivery to safely give birth. By contrast, there were relatively few studies 
that drew on population-based surveys or targeted community samples; our review had insufficient 
data from women and men living in communities with high burden of FGM/C and fistula. This 
selection bias likely lead to an underreporting of evidence on the association of FGM/C and fistula, 
given that these groups are less likely have access to medical services overall and more likely to 
experience a co-occurrence of both conditions. Also, a paucity of longitudinal quantitative designs 
limits our ability to detect causal inference; however, conducting such studies is not pragmatic in 
most settings given the long data collection time-frame required to collect relevant information, the 
relative rarity of fistula, and the high rates of loss-to-follow up (WHOb 2006). 
Implications for research, programming, and policy 
Despite these limitations, this rigorous review of the literature points to the lack of an in-depth 
understanding around the contexts in which associations between various types of FGM/C and 
different types of fistula exist and require more deliberate programming efforts. The conceptual 
mapping presented in this report may serve as a particularly useful tool for those involved in 
programming in that it may help decision makers think through the various consequences, positive 
and negative, of intervening at various levels. First contexts in which FGM/C is a norm ought to 
more systematically take the associated risks of fistula and other childbirth outcomes into account. 
For example, the type of provider counseling intervention may differ between HIC and LMIC 
contexts based on the types of FGM/C and fistula women typically present with. A social norms 
targeting program strategy may require a variety of inputs including increasing male and female 
awareness around the risks of FGM/C on maternal and newborn outcomes and soliciting buy-in of 
community leaders. The quality of care and underlying factors that affect both FGM/C and fistula 
point to the importance of advocating for multifaceted girl-centered policy and programming. 
There is a need to build the evidence base around understanding and addressing the association 
of FGM/C and fistula. A second phase of this study is planned and will undertake limited 
multivariate analyses of the DHS/MICS datasets from multiple African countries that have the 
relevant data to investigate the associations, causative factors and relevant correlates for FGM/C 
and fistula. Comparative research across high and low burden FGM/C settings, types of cutting, 
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socio-economic status, and country policy environments would be useful for shared learning on 
this ambiguous area in both LMIC and HIC contexts. We recommend that researchers focus on 
studying confounders, mediators, and underlying factors as related to both FGM/C and fistula at 
the community level and in high burden settings where both are prevalent. High burden FGM/C 
settings may be in HICs and LMICs, including among migrants or other underserved populations 
that lack access to proper pregnancy and delivery care. The association of FGM/C and traumatic 
fistula may be directly explored in contexts where women are exposed to sexual violence, for 
example in conflict and post-conflict settings. Traumatic fistula should also be further studied in 
contexts where unskilled persons are performing FGM/C procedures and unintended injury directly 
results in fistula formation.  
We recommend utilising the conceptual mapping as a guide to look at different complex 
relationships between factors through both qualitative and quantitative means. Qualitatively, it is 
critical to explore multiple perspectives around FGM/C and fistula to better develop contextually 
sound interventions. Quantitatively, we recommend the use of latent variables, scales and indices 
to investigate the influence of positive and negative social norms, health systems, and poverty on 
both FGM/C and fistula in high FGM/C exposure areas. Implementation research around 
psychosocial interventions that addresses depression, anxiety, social and cultural challenges 
associated with both conditions is a key investigative space to pursue—especially in LMIC contexts 
where the double burden of FGM/C and fistula is more pronounced. Finally, it is important to 
conduct further nuanced research on the influence of laws, policies and professional guidelines for 
health workers around FGM/C (e.g. related to re-infibulation and deinfibulation) and how these 
affect the experience of women in HIC and LMIC contexts. 
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